Inventor · disambiguated record
Jianhua Sui
Also filed as: SUI JIANHUA
17 granted patents·15 pending applications·69 citations·filing 2004–2022
92Inventor score
Files withDANA FARBER CANCER INST INC15HUAHUI HEALTH LTD7MARASCO WAYNE A3MARASCO WAYNE2NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING2
Top patents by PatentIndex Score
32 records- 0189US7750123B2Antibodies against SARS-CoV and methods of use thereofDANA FARBER CANCER INST INC·Filed 2004·Granted Jul 6, 2010·20 cites·4 claims
- 0288US8329178B2Antibodies against CXCR4 and methods of use thereofMARASCO WAYNE A·Filed 2006·Granted Dec 11, 2012·14 cites·8 claims
- 0387US9828434B2Human monoclonal anti-PD-L1 antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2013·Granted Nov 28, 2017·8 cites·11 claims
- 0487US9527924B2Humanized monoclonal antibodies and methods of useMARASCO WAYNE A·Filed 2011·Granted Dec 27, 2016·8 cites·4 claims
- 0585US11485774B2Anti-pre-S1 HBV antibodiesHUAHUI HEALTH LTD·Filed 2019·Granted Nov 1, 2022·2 cites·8 claims
- 0684US9951122B2Antibodies against influenza virus and methods of use thereofDANA FARBER CANCER INST INC·Filed 2013·Granted Apr 24, 2018·4 cites·9 claims
- 0783US12509504B2Method of treating HBV infection by using anti-pre-S1 HBV antibodiesHUAHUI HEALTH LTD·Filed 2020·Granted Dec 30, 2025·1 cites·9 claims
- 0882US10544205B2Anti-Pre-S1 HBV antibodiesHUAHUI HEALTH LTD·Filed 2018·Granted Jan 28, 2020·3 cites·8 claims
- 0980US10604581B2Human monoclonal anti-PD-L1 antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Mar 31, 2020·1 cites·15 claims
- 1080US9441045B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2013·Granted Sep 13, 2016·2 cites·6 claims
- 1178US9416169B2Humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Aug 16, 2016·2 cites·18 claims
- 1274US8962806B2Humanized monoclonal antibodies and methods of useMARASCO WAYNE·Filed 2008·Granted Feb 24, 2015·3 cites·13 claims
- 1373US10179822B2Humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 15, 2019·1 cites·24 claims
- 1464US10774134B2Conserved hemagglutinin epitope, antibodies to the epitope, and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Sep 15, 2020·0 cites·13 claims
- 1564US2021221873A1Conserved hemagglutinin epitope, antibodies to the epitope, and methods of useDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1664US2020385482A1Human monoclonal anti-pd-l1 antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1761US2011038935A1Antibodies against influenza virus and methods of use thereofMARASCO WAYNE A·Filed 2008·Application pending·0 cites
- 1860US2018094064A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1960US2019276544A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 2059US2012128684A1Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of UseMARASCO WAYNE·Filed 2009·Application pending·0 cites
- 2158US9587028B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Mar 7, 2017·0 cites·6 claims
- 2258US2018312575A1Antibodies against influenza virus and methods of use thereofDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 2356US2024391990A1Bi-functional fusion protein and uses thereofTANG NAN·Filed 2022·Application pending·0 cites
- 2455US10584172B2Humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Mar 10, 2020·0 cites·5 claims
- 2555US2025084177A1Anti-cd98 antibodies and uses thereofHUAHUI HEALTH LTD·Filed 2021·Application pending·0 cites
- 2654US2024076412A1A bispecific antibody targeting gpc3 and cd47NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2022·Application pending·0 cites
- 2754US2018094047A1Anti-pre-s1 hbv antibodiesHUAHUI HEALTH LTD·Filed 2016·Application pending·0 cites
- 2852US2023041071A1Antibodies against areg and its useNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2022·Application pending·0 cites
- 2950US2023348880A1Soluble ace2 and fusion protein, and applications thereofHUAHUI HEALTH LTD·Filed 2021·Application pending·0 cites
- 3040US12421307B2Anti-FGF19 antibodiesHUAHUI HEALTH LTD·Filed 2020·Granted Sep 23, 2025·0 cites·16 claims
- 3140US2009130123A1Antibodies to west nile virus polypeptidesFIKRIG EROL·Filed 2005·Application pending·0 cites
- 3231US2020319186A1Markers for diagnosis and prognostic prediction of npc and application thereofSUN YAT SEN UNIV CANCER CENTER SYSUCC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianhua Sui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →